Skip to content

ANEVASC

Active Private limited companyfounded 2011active for 15 yearsScheepswerfstraat 13, 9200 DendermondeKBO/BCE: BE 0832.982.352 #6 company by equity in Dendermonde, Health and social work sector

Lifetime

15 annual accounts with figures on one time axis
peak of €715,482 in 2023
€637,543▲ 3.0%
peak of €479,469 in 2023
€383,505▼ 8.7%
peak of €2.0m in 2025
€2.0m▲ 7.8%
€358,038▲ 265%
peak of 0 FTE in 2023
0 FTE 
Board3 names since 2011
3 directors and 2 others
Documentsfilings and deeds
15-10-202676 days late
2025abbreviated format
Dividend €238,194Debts from €98,131 to €358,038Investments €337,500

Key points

from the 2025 annual accounts

Equity

€2.0m ▲ 7.8%
1.92024+0.4Profit-0.2Dividend2.02025

ANEVASC paid out €238,194 in dividends. That is 62% of the 2025 profit.

Turnover

≈ €960,000 estimated

The abbreviated format states no turnover.

Investments

€375,000 14.7 times depreciation
20212022202320242025

Green is investment, beige is depreciation.

Liquidity

46.85 was 18.91 in 2024

Short-term debts fell from €98,131 to €41,591.

Filings

15 annual accounts 76 days
AprilJune31 JulyOctober201520202025

Latest accounts filed late: after the legal deadline.

Position in the sector

€2.0m

More equity than 85% of companies in human health. Sector median €435,715 · 2,821 companies.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 17,816 companies had the same profile as ANEVASC has now. Each dot stands for 45 companies, two years later.

96.5%
were still trading
3.2%
stopped another way
0.3%
went bankrupt
  • Small
  • 10 to 20 years old
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more
Test of the method

The method was tested on the 497,965 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 2.9% 3.1%
10 5.6% 6.1%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 17,816 companies, not a prediction for ANEVASC. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Manager
Director
Director
Board & ownership

Recent changes

Company renamed from Dr. J.Callaert - vaatheelkunde & Dr. N. Van Dam - anesthesie to ANEVASC (statutory director) and (statutory director) reappointed · “De uitoefening van de geneeskunde door de arts-vennoot,dit alles in naam en voor rekening van de…” (deed in Dutch) · General meeting of 22-12-2023 · Gazette deed
Registered in the Peppol Directory Reachable for e-invoices through 0208:0832982352
Incorporation Founded by and · Founding capital of €18,600, 186 shares, €6,200 paid up · (statutory manager) and (statutory manager) appointed · published on 01-02-2011 · Gazette deed
All 26 events

Comparable companies

same main activity, similar in size and age
Company
ANEVASC Dendermonde €2.4m €637,543 84.9% 0
MICRUROL Herentals €2.3m €646,637 89.3% 0
SYOPA Zoersel €2.2m €608,695 68.4% 0
DR. CASTILLE, ANESTHESIST Destelbergen €2.1m €657,092 93.1% 0
Dr. Matthias Desmet - Dr. Sofie Decock Bruges €2.3m €759,974 81.7% 0
RADIOLOGIE VAN RILLAER Antwerp €2.9m €658,156 15.0% 0
PROF. DR. VERDONK-ORTHOPEDIE Antwerp €2.7m €780,984 78.0% 0

These companies have the same main activity as ANEVASC: specialist medical practice (NACE 86220). They are comparable in size and age: total assets between €2.1m and €2.9m, founded between 2009 and 2014.

Official details

Source: KBO
Status
Active since 20-01-2011Normal situation
Activity
Specialist medical practiceNACE 86220
Financial year end
31 December
Peppol
Reachable since 24-11-2023
Company details

Annual accounts 2025

€2.4m▲ 20.5%
Filing
Filed on 15-10-2026
Financials

Insights on ANEVASC

ANEVASC files the abbreviated format. That format states no turnover. The gross margin rose from €297,336 in 2011 to €637,543 in 2025.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about ANEVASC

What is the company number of ANEVASC?
The company number of ANEVASC is 0832.982.352. The VAT number is the same number with BE in front: BE 0832.982.352.
Where is ANEVASC based?
The registered office is at Scheepswerfstraat 13, 9200 Dendermonde.Company details
What does ANEVASC do?
According to the KBO register, the main activity is specialist medical practice (NACE 86220).
What is the legal form of ANEVASC?
ANEVASC is a private limited company (BV).
When was ANEVASC founded?
ANEVASC was founded on 20-01-2011.
Is ANEVASC still active?
Yes, ANEVASC is an active enterprise in the KBO register.
What is the turnover of ANEVASC?
The turnover in financial year 2025 is ≈ €960,000. This figure is estimated from the gross margin of €637,543 and 31 comparable companies (NACE 86220). It probably lies between €850,000 and €1.3m.Financials
Is ANEVASC profitable?
In financial year 2025, ANEVASC made a profit of €383,505.
Where can I find the annual accounts of ANEVASC?
ANEVASC filed 15 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of ANEVASC due?
ANEVASC must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.